Northpond Ventures
Emily Wooten is a Senior Analyst of Portfolio Operations at Northpond Ventures. Emily supports internal and external reporting, as well as the firm’s quarterly evaluation process. Previously, Emily was a Portfolio Analyst for the International Finance Corporation where she performed data analysis across the disruptive technologies portfolio to support and make more informed investment decisions. Earlier, Emily was an Analyst for The Carlyle Group (NASDAQ: CG), working across the Asia and Emerging Markets platform on fundraising, marketing, client reporting, and quarter evaluations. Emily received a B.S. in financial technology from Virginia Commonwealth University.
This person is not in any offices
Northpond Ventures
Northpond Ventures is a leading global science, medical, and technology-driven venture firm dedicated to building and empowering breakthrough companies in life sciences and technology. Northpond has in excess of $1 billion of committed capital, with over 21 businesses represented in its portfolio. The firm’s investments target the greatest scientists, innovators, and entrepreneurs in life sciences, diagnostics, AI and machine learning, therapeutics, and affiliated sectors. Northpond has become among the most active investors in the life sciences and molecular diagnostics industries.